年轻成年人中的 riboflavin 载体缺陷被饮食变化所揭露
Bregje Jaeger1, Mirjam Langeveld2, Robert Brunkhorst3
1Department of Child Neurology Emma Children's Hospital, Amsterdam University Medical Centers Amsterdam The Netherlands.
JIMD reports
|July 8, 2024
概括
减少 рибофлавин的摄入量可以触发成人的 рибофлавин载体缺乏症 (RTD),导致神经系统的快速衰退. 高剂量里博弗拉治疗有效地逆转了症状,突出了早期诊断和干预的重要性.
科学领域:
- 神经学 神经学
- 遗传学 是一个遗传学.
- 营养科学 营养科学
背景情况:
- рибофлавин载体缺乏症 (RTD) 是一种影响维生素B2摄取的遗传疾病,通常在儿童时期出现神经功能障碍.
- 晚期发病的RTD较少见,往往进展缓慢,使得诊断具有挑战性.
研究的目的:
- 报告三名年轻成年人的快速进展的神经症状归因于RTD,由饮食变化引发.
- 突出RTD在晚年呈现的潜力和高剂量 riboflavin 治疗的疗效.
主要方法:
- 一系列案例报告了三个患有神经衰退的年轻人.
- 诊断工作,包括遗传评估 (隐含).
- 使用高剂量口服里博夫拉 (20-40毫克/公斤/天) 的治疗.
主要成果:
- 在减少肉类和乳制品摄入量后,三名以前健康的年轻人出现了快速的神经衰退.
- 确认了对利博弗拉载体缺乏症的诊断.
- 高剂量里博弗拉治疗导致部分症状逆转.
结论:
- 减少饮食里玻拉摄入量可以揭露成年人的RTD,导致急性神经症状.
- 早期识别和治疗RTD与高剂量里博弗拉对于扭转潜在致命的神经功能障碍至关重要.
相关概念视频
Lipids: Dietary Sources and Requirements
718
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
718
Vitamins
653
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
653
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Carbohydrates: Dietary Sources and Requirements
460
Carbohydrates are predominantly obtained from plant sources. With the exception of lactose found in milk and insignificant glycogen amounts in meat, most consumed carbohydrates have plant origins. Monosaccharides and disaccharides, or sugars, can be sourced from fruits, honey, milk, sugar cane, and sugar beets. Grains and vegetables are rich in the polysaccharide starch. Two types of polysaccharides provide fiber: cellulose, which is abundant in many vegetables, forms undigestible roughage or...
460
Factors Affecting Drug Biotransformation: Biological
139
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
139
Factors Affecting Protein-Drug Binding: Patient-Related Factors
56
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
56


